CBE ID
0586
1.4 Project
Endorsed
Endorsement Status
1.1 New or Maintenance
E&M Cycle
Is Under Review
No
1.3 Measure Description
This measure identifies the percentage of patients taking warfarin during the measurement year who had at least one PT/INR test within 30 days after the first warfarin prescription in the measurement year
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
Patients in the denominator who had a PT/INR test within 30 days after the first warfarin claim during the measurement year
Time Window: See below
-
1.15 Denominator
Patients who are taking warfarin during the measurement year
Time Window: See below
-
Exclusions
Claims from the hospital or ER from the warfarin start date to warfarin start date + 30 days
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Patient Safety Project 2013-2014Initial EndorsementLast UpdatedRemoval Date
-
StewardSteward Organization Email
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)6.1.3 Current Use(s)
-